BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4055261)

  • 1. Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
    Page CP; Archer CB; Guerreiro D; Morley J
    Int J Tissue React; 1985; 7(5):351-4. PubMed ID: 4055261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-acether: a putative mediator of asthma and inflammation.
    Page CP; Paul W; Dewar A; Wood L; Basran GS; Morley J
    Agents Actions Suppl; 1983; 13():177-83. PubMed ID: 6575595
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between PAF, platelets and eosinophils in bronchial asthma.
    Page CP; Coyle AJ
    Eur Respir J Suppl; 1989 Jun; 6():483s-487s. PubMed ID: 2679601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF-acether and experimental anaphylaxis as a model for asthma.
    Pretolani M; Lellouch-Tubiana A; Lefort J; Bachelet M; Vargaftig BB
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):149-53. PubMed ID: 2540093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF, eosinophils and asthma.
    Barnes PJ
    J Lipid Mediat; 1992; 5(2):155-8. PubMed ID: 1525357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for platelet-activating factor in asthma.
    Chung KF; Barnes PJ
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
    Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K
    J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma as a chronic inflammatory disease and the implications for future therapy.
    Page C
    Ann Allergy; 1992 Sep; 69(3):251-60. PubMed ID: 1355953
    [No Abstract]   [Full Text] [Related]  

  • 11. PAF-acether and eosinophils.
    Hénocq E
    Prog Biochem Pharmacol; 1988; 22():141-8. PubMed ID: 3043428
    [No Abstract]   [Full Text] [Related]  

  • 12. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
    Shindo K; Koide K; Fukumura M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PAF-acether in the vascular events of inflammation.
    Lagente V; Fortes ZB
    Prog Biochem Pharmacol; 1988; 22():149-55. PubMed ID: 3043429
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet activating factor in allergies.
    Pałgan K; Bartuzi Z
    Int J Immunopathol Pharmacol; 2015 Dec; 28(4):584-9. PubMed ID: 26486136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma.
    Page CP; Morley J
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():217-37. PubMed ID: 3774847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of platelet-activating factor (PAF) on eosinophil adhesion to plasma-coated glass using eosinophilic cell lines (EoL-1, EoL-3)].
    Kakazu T; Chihara J; Saito A; Hayashi N; Higashimoto I; Kurachi D; Yamamoto T; Nakajima S
    Arerugi; 1994 Apr; 43(4):590-4. PubMed ID: 8031255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist.
    Guinot P; Braquet P; Duchier J; Cournot A
    Prostaglandins; 1986 Jul; 32(1):160-3. PubMed ID: 3763944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of platelet activating factor in the pathogenesis of asthma].
    Péc M; Visnovský P; Dobrota D; Dobiás J; Lazár J
    Bratisl Lek Listy; 1993 Sep; 94(9):507-9. PubMed ID: 8004503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.